Zinc Finger Protein St18 Protects against Septic Death by Inhibiting VEGF-A from Macrophages.

Maruyama, Kenta; Kidoya, Hiroyasu; Takemura, Naoki; Sugisawa, Erika; Takeuchi, Osamu; Kondo, Takeshi; Eid, Mohammed Mansour Abbas; Tanaka, Hiroki; Martino, Mikaël M; Takakura, Nobuyuki; Takayama, Yasunori; Akira, Shizuo; Vandenbon, Alexis; Kumagai, Yutaro

Zinc finger protein St18 was initially reported as candidate tumor suppressor gene, and also suggested that fibroblast St18 positively regulates NF-κB activation. Despite the pleiotropic functions of St18, little is known about its roles in macrophages. Here, we report that myeloid St18 is a potent inhibitor of VEGF-A. Mice lacking St18 in myeloid lineages exhibit increased retinal vasculature with enhanced serum VEGF-A concentrations. Despite the normal activation of NF-κB target genes, these mice are highly susceptible to LPS-induced shock, polymicrobial sepsis, and experimental colitis, accompanied by enhanced vascular and intestinal leakage. Pharmacological inhibition of VEGF signaling rescued the high mortality rate of myeloid-specific St18-deficient mice in response to inflammation. Mechanistically, St18 directly binds to Sp1 and attenuates its activity, leading to the suppression of Sp1 target gene VEGF-A. Using mouse genetic and pharmacological models, we reveal myeloid St18 as a critical septic death protector.